Today’s drug market redefines the phrase “drug pushing.” The pharmaceutical companies “push” research with funding and “push” their products on medical journals and medical associations and physicians, and the physicians ultimately “push” the drugs on their patients.
Many of these psychiatric disorders are contrived for the purpose of selling drugs, but think of the implications of some of them. “Disruptive behavior disorder” means getting out of line and challenging authority. Kids are being trained, some from toddlerhood, that resistance to authority is a mental illness.
The United States has become the psychiatric drugging capital of the world for kids with children being medicated at a younger and younger age. Medicaid records in some states show infants less than a year old on drugs for mental disorders.
The use of powerful antipsychotics with privately insured children, aged 2 through 5 in the US, doubled between 1999 and 2007, according to a study of data on more than one million children with private health insurance in the January, 2010, “Journal of the American Academy of Child & Adolescent Psychiatry.”
The number of children in this age group diagnosed with bipolar disorder also doubled over the last decade, Reuters reported.
Of antipsychotic-treated children in the 2007 study sample, the most common diagnoses were pervasive developmental disorder or mental retardation (28.2%), ADHD (23.7%), and disruptive behavior disorder (12.9%).
Read more at AlterNet.